NCT01638429View on ClinicalTrials.gov

Role of Methane in Glycemic Control

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
DiabetesObesity
Interventions
DRUG

Neomycin

Neomycin: 500mg po bid for 10 days

DRUG

Rifaximin

Rifaximin: 550mg po tid for 10 days

Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
collaborator

American Diabetes Association

OTHER

lead

Cedars-Sinai Medical Center

OTHER

NCT01638429 - Role of Methane in Glycemic Control | Biotech Hunter | Biotech Hunter